BNVID

Related by string. BNVI * * symbol BNVI . Inc. Nasdaq BNVI . NASDAQ BNVI . Nasdaq BNVI *

Related by context. Frequent words. (Click for all words.) 77 AKRX 75 LXRX 75 Calls Purchased 75 Teva Pharm Ind TEVA 75 AUXL 74 Guides FY# Quick Facts 74 ENZN 74 BPAX 74 DVAX 73 THE TREND CONTINUES DOWN 73 VTIV 73 CRXX 73 THE TREND CONTINUES LOWER 73 Options Trader Alert 73 Inc. NASDAQ RRGB 73 IDIX 73 IMMU 72 DOWNTREND SPOTTED IN SHARES 72 VRUS 72 Interesting Options Volume 72 IT REPORTS EARNINGS 72 QLTI 72 OPTR 72 SMARTREND RESEARCH REPORT AVAILABLE 72 QGEN 71 CADX 71 AVANIR Pharmaceuticals 71 Bullish Engulfing Pattern 71 #.#X ABOVE AVERAGE VOLUME 71 ALTH 71 POZN 71 RELEASES ITS QUARTERLY NUMBERS 71 ISPH 71 RPRX 71 SGMO 71 CYTR 71 Stock Upgraded 71 INCY 71 SMARTREND 'S OPTION SCANNER 71 #/#/# PriceWatch Alert Technicals [001] 71 Stock Downgraded 71 WEEK HIGH RECENTLY ECLIPSED 70 Abraxis trades 70 Detects Unusual Activity 70 BEARISH MOVING AVERAGE CROSSOVER 70 Options Activity 70 IMGN 70 TRGL 70 OSIR 70 UPWARD MOMENTUM LOOKS TO 70 THE TREND CONTINUES UP 70 www.labopharm.com 70 lululemon athletica inc 70 EARNINGS LOOK AHEAD 70 GTXI 70 Novartis Ag 70 Inc. Nasdaq IMGN 70 THE TREND CONTINUES HIGHER 70 ACADIA Pharmaceuticals 70 SCLN 70 SHARES COULD PULLBACK 70 AMRN 70 UPTREND SPOTTED IN SHARES 70 www.questcor.com 70 RELEASES ITS QUARTERLY EARNINGS 70 AFFY 70 PriceWatch Alert Technicals Showing 70 BREAKS THROUGH SUPPORT 70 REACHES INITIAL SUPPORT LEVEL 70 Transcept Pharmaceuticals 70 PYMX 70 HIGHER PRICES ON #.#X 69 OUT IN SHARES 69 NASDAQ ARIA 69 DOWNWARD MOMENTUM LOOKS TO 69 VICL 69 Company Nasdaq PRGO 69 please visit www.amex.com 69 PATTERN FOR 69 PLEASE REFER TO 69 WATCH FOR CONTINUED GAINS 69 Inc Therapeutic Competitors 69 DETECTS UNUSUAL ACTIVITY IN 69 GNTA 69 MATK 69 NASDAQ SVNT 69 THERAPEUTICS 69 TO PULLBACK AFTER YESTERDAY 69 SMARTREND DETECTS CONTINUED SELLING 69 VNDA 69 NASDAQ CYPB 69 AXTI 69 TRADING HIGHER ON #.#X 69 www.syntapharma.com 69 CROSSES PIVOT POINT SUPPORT 69 DYAX 69 Bearish Harami Pattern 69 Cyclacel Pharmaceuticals 69 'S QUARTERLY RESULTS 69 Forecast Quick Facts 69 OFFERS INVESTORS BETTER VALUE

Back to home page